AF
TNXP icon

Allworth Financial’s Tonix Pharmaceuticals TNXP Stock Holding History

Allworth Financial’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.4K Buy
1,053
+823
+358% +$10.6K ﹤0.01% 3511
2026
Q1 		$3.16K Buy
230
+220
+2,200% +$3.39K ﹤0.01% 4185
2025
Q4 		$157 Buy
+10
New +$184 ﹤0.01% 4732
2025
Q1 		– Hold
0
– -$1 – 4182
2024
Q4 		– Hold
0
– – – 3936
2024
Q3 		– Hold
0
– – – 3744
2024
Q2 		– Hold
0
– – – 3688
2024
Q1 		– Hold
0
– – – 3596
2023
Q1 		– Hold
0
– -$390 – 3291
2022
Q4 		– Hold
0
– – – 2690

Other funds holding TNXP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
II
Ishara Investments Los Angeles, California $136M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Allworth Financial's TNXP Position: Q2 2026 in Review

Allworth Financial increased its Tonix Pharmaceuticals (TNXP) stake by 358% in Q2 2026, buying an estimated $10.6K and bringing the position to 1,053 shares worth $13.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3511.

Allworth Financial first reported a position in TNXP in Q4 2025 and has held it in 3 quarters since. 103 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • Allworth Financial held 1,053 shares of Tonix Pharmaceuticals worth $13.4K as of Q2 2026.
  • Allworth Financial bought 823 Tonix Pharmaceuticals shares in Q2 2026, an estimated $10.6K.
  • Tonix Pharmaceuticals made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3511 holding.
  • Allworth Financial first reported a position in Tonix Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 103 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.